ConductScience.org, home

Paper39723908

TKK130 is a 3-Hydroxy-Propanamidine (HPA) with Potent Antimalarial In Vivo Activity and a High Barrier to Resistance.

Knaab TC and 15 others. J Med Chem, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. TKK130 is a 3-Hydroxy-Propanamidine (HPA) with Potent Antimalarial In Vivo Activity and a High Barrier to Resistance. Papers, record 39723908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39723908

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
TKK130 is a 3-Hydroxy-Propanamidine (HPA) with Potent Antimalarial In Vivo Activity and a High Barrier to Resistance.
PubMed
Journal
J Med Chem
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-08-13
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Knaab TCTanja C
2Moritz AAlena
3Pessanha de Carvalho LLais
4Klein SSaskia
5Lungerich BBeate
6Lohse KKatharina
7Kruse LLinn
8Mombo-Ngoma GGhyslain
9Orta LLily
10Thibaud JLJessica L
11de Villiers KAKatherine Ahttps://orcid.org/0000-0002-2932-395X
12Fidock DADavid A
13Burckhardt BBBjoern Bhttps://orcid.org/0000-0002-1782-9937
14Held JJanahttps://orcid.org/0000-0002-7970-1429
15Wittlin SSergiohttps://orcid.org/0000-0002-0811-0912
16Kurz TThomashttps://orcid.org/0000-0002-9474-4224

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntimalarialsMajor topic
Plasmodium falciparumMajor topic
Drug ResistanceMajor topic
Mice, SCIDMajor topic
Animals
Humans
Mice
Structure-Activity Relationship
Malaria
Plasmodium berghei
Amidines
Malaria, Falciparum
Hemeproteins

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 AI109023NIAID NIH HHSUnited StatesR01AI109023PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References46

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125453091(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/25453091PubMed
214729380Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells.Eur J Pharmacol2004https://conductscience.org/library/papers/14729380PubMed
331109978Ivermectin Impairs the Development of Sexual and Asexual Stages of Plasmodium falciparum In Vitro.Antimicrob Agents Chemother2019https://conductscience.org/library/papers/31109978PubMed
435096650Boromycin has Rapid-Onset Antibiotic Activity Against Asexual and Sexual Blood Stages of Plasmodium falciparum.Front Cell Infect Microbiol2021https://conductscience.org/library/papers/35096650PubMed
5286538453-Hydroxy-N'-arylidenepropanehydrazonamides with Halo-Substituted Phenanthrene Scaffolds Cure P. berghei Infected Mice When Administered Perorally.J Med Chem2017https://conductscience.org/library/papers/28653845PubMed
618493601A murine model of falciparum-malaria by in vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes.PLoS One2008https://conductscience.org/library/papers/18493601PubMed
725114138Antimalarial activity of the myxobacterial macrolide chlorotonil a.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/25114138PubMed
819596869Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2Rgammanull mice engrafted with human erythrocytes.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19596869PubMed
915745752A colorimetric high-throughput beta-hematin inhibition screening assay for use in the search for antimalarial compounds.Anal Biochem2005https://conductscience.org/library/papers/15745752PubMed
1020230372Lipophilic mediated assays for beta-hematin inhibitors.Comb Chem High Throughput Screen2010https://conductscience.org/library/papers/20230372PubMed
1122096101Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.Science2011https://conductscience.org/library/papers/22096101PubMed
1225516843Identification of β-hematin inhibitors in a high-throughput screening effort reveals scaffolds with in vitro antimalarial activity.Int J Parasitol Drugs Drug Resist2014https://conductscience.org/library/papers/25516843PubMed
1333126289Low-volume LC-MS/MS method for the pharmacokinetic investigation of carvedilol, enalapril and their metabolites in whole blood and plasma: Application to a paediatric clinical trial.Drug Test Anal2021https://conductscience.org/library/papers/33126289PubMed
1438321292Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa.Nat Rev Microbiol2024https://conductscience.org/library/papers/38321292PubMed
1534001441Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials.Trends Parasitol2021https://conductscience.org/library/papers/34001441PubMed
1628225668Emergence of Indigenous Artemisinin-Resistant Plasmodium falciparum in Africa.N Engl J Med2017https://conductscience.org/library/papers/28225668PubMed
1719438171Simple size-independent measure of ligand efficiency.J Chem Inf Model2009https://conductscience.org/library/papers/19438171PubMed
1825487796Identification and deconvolution of cross-resistance signals from antimalarial compounds using multidrug-resistant Plasmodium falciparum strains.Antimicrob Agents Chemother2015https://conductscience.org/library/papers/25487796PubMed
1936471200Addressing the Accuracy of Plasma Protein Binding Measurement for Highly Bound Compounds Using the Dilution Method.AAPS J2022https://conductscience.org/library/papers/36471200PubMed
2026085270A novel multiple-stage antimalarial agent that inhibits protein synthesis.Nature2015https://conductscience.org/library/papers/26085270PubMed

See all 46 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42732910Tearing Down Scientific Boundaries: Frontiers in Medicinal Chemistry 2026.ChemMedChem2026https://conductscience.org/library/papers/42732910PubMed
41808149Integrative preclinical strategy for pharmacokinetic profiling and candidate selection of 3-hydroxypropanamidines: a promising antimalarial class.Malar J2026https://conductscience.org/library/papers/41808149PubMed
40921080Structure-Activity Relationships of 3-Hydroxypropanamidines (HPAs) with Potent In Vivo Antimalarial Activity.J Med Chem2025https://conductscience.org/library/papers/40921080PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39723908

GET https://conductscience.org/api/papers/v1/39723908/references?page=2